Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 10-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 22)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
6-Feb-10 Reuters Investment Profile N/A The Andhra Sugars Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: ANADYS PHARMACEU -- ANDS 1 $4 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: ACOR , AFFY , ANDS , BSTC , OMPI , TELK -- DRUGS 3 $4 View Abstract
5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ANADYS PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
4-Feb-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Anadys Pharmaceuticals, Inc. 40 $65 View Abstract
2-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for ANDS: the economy's impact on ANDS's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
26-Jan-10 Zacks Investment Research Inc. N/A ANADYS PHARMACT (ANDS) Zacks Company Snapshot 1 $10 View Abstract
11-Jan-10 Zacks Investment Research Inc. N/A ANADYS PHARMACT (ANDS) Zacks Company Snapshot 1 $10 View Abstract
6-Jan-10 Global Markets Direct Global Markets Direct Anadys Pharmaceuticals, Inc Financial and Strategic Analysis Review 20 $300 View Abstract
5-Jan-10 Zacks Investment Research Inc. N/A ANADYS PHARMACT (ANDS) Zacks Company Snapshot 1 $10 View Abstract
Next 12

Independent Reports (Showing 1 to 10 of 22)

Release
Date Contributor Author Title Pages Price More Info
6-Feb-10 Reuters Investment Profile N/A The Andhra Sugars Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: ANADYS PHARMACEU -- ANDS 1 $4 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: ACOR , AFFY , ANDS , BSTC , OMPI , TELK -- DRUGS 3 $4 View Abstract
5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ANADYS PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
4-Feb-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Anadys Pharmaceuticals, Inc. 40 $65 View Abstract
2-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for ANDS: the economy's impact on ANDS's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
26-Jan-10 Zacks Investment Research Inc. N/A ANADYS PHARMACT (ANDS) Zacks Company Snapshot 1 $10 View Abstract
11-Jan-10 Zacks Investment Research Inc. N/A ANADYS PHARMACT (ANDS) Zacks Company Snapshot 1 $10 View Abstract
6-Jan-10 Global Markets Direct Global Markets Direct Anadys Pharmaceuticals, Inc Financial and Strategic Analysis Review 20 $300 View Abstract
5-Jan-10 Zacks Investment Research Inc. N/A ANADYS PHARMACT (ANDS) Zacks Company Snapshot 1 $10 View Abstract
Next 12

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.